| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 119,478 | 121,132 | 109,700 | 92,934 | | Cost of Revenue | 73,365 | 80,345 | 72,239 | 59,913 | | | Gross Profit | 46,113 | 40,787 | 37,461 | 33,021 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 28,874 | 20,872 | 18,008 | 18,530 | | Non Recurring | (138) | 130 | 8 | 210 | | Others | 7,443 | 7,314 | 7,274 | 7,418 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,765 | 12,471 | 12,171 | 6,863 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,972) | (12) | 451 | (417) | | Earnings Before Interest And Taxes | 6,962 | 12,459 | 12,622 | 6,253 | | Interest Expense | 11,849 | 9,944 | 9,936 | 9,860 | | Income Before Tax | (4,887) | 2,515 | 2,686 | (3,607) | | Income Tax Expense | (2,779) | 1,598 | 1,184 | (1,702) | | Minority Interest |
-
|
-
|
-
| (30) | | | | Net Income From Continuing Ops | (2,108) | 917 | 1,502 | (1,935) | | | Non-recurring Events | | Discontinued Operations | 2,685 | (565) | (750) | (2,602) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 577 | 352 | 752 | (4,537) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $577 | $352 | $752 | ($4,537) |
|
0.20% Nasdaq 
Income Statement
